PharmaBlock Sciences (Nanjing) Management
Management criteria checks 2/4
PharmaBlock Sciences (Nanjing)'s CEO is Minmin Yang, appointed in Apr 2023, has a tenure of 1.5 years. directly owns 20.82% of the company’s shares, worth CN¥1.44B. The average tenure of the management team and the board of directors is 1.6 years and 2.9 years respectively.
Key information
Minmin Yang
Chief executive officer
CN¥860.0k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 1.5yrs |
CEO ownership | 20.8% |
Management average tenure | 1.6yrs |
Board average tenure | 2.9yrs |
Recent management updates
Recent updates
PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) P/E Is Still On The Mark Following 40% Share Price Bounce
Sep 30PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Aug 23We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt
Jul 31PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Increasing Its Dividend To CN¥0.31
Jun 12PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Apr 21PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Looks Just Right With A 25% Price Jump
Mar 07CEO
Minmin Yang (52 yo)
1.5yrs
Tenure
CN¥860,000
Compensation
Dr. Minmin Yang, Ph D., serves as Director of Myrobalan Therapeutics Holding, Inc. He is Co-Founder at PharmaBlock Sciences (Nanjing), Inc and has been its Chairman since December 2014. Dr. Yang serves as...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 1.5yrs | CN¥860.00k | 20.82% CN¥ 1.4b | |
Secretary | 3.3yrs | CN¥1.05m | no data | |
Chief Technology Officer | 1.8yrs | CN¥2.29m | 0.020% CN¥ 1.4m | |
Sr. VP of Process Chemistry & President of PharmaBlock (USA) | no data | CN¥1.97m | no data | |
Co-founder & Chief Scientific Officer | no data | CN¥344.50k | no data | |
Executive VP | less than a year | no data | no data | |
Sr. VP of Process Technology & Manufacturing | no data | no data | no data |
1.6yrs
Average Tenure
52yo
Average Age
Experienced Management: 300725's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 9.8yrs | CN¥860.00k | 20.82% CN¥ 1.4b | |
Non-Independent Director | 1.4yrs | CN¥520.00k | no data | |
Non-Employee Supervisor | 2.9yrs | CN¥747.60k | no data | |
Non-Employee Supervisor | 2.9yrs | no data | no data | |
Director | 2.9yrs | CN¥1.02m | no data | |
Independent Director | 2.9yrs | CN¥80.00k | no data | |
Independent Director | 2.9yrs | CN¥80.00k | no data | |
Independent Director | 2.9yrs | CN¥80.00k | no data |
2.9yrs
Average Tenure
49yo
Average Age
Experienced Board: 300725's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.